Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice

References

• Antoch M, Kondratov R. (2013). Pharmacological modulators of the circadian clock as potential therapeutic drugs: Focus on genotoxic/anticancer therapy. In Kramer A, Merrow M, eds. Circadian clocks. Berlin–Heidelberg: Springer, pp. 289–309
   Google Scholar
• Antoch MP, Song E-J, Chang A-M, et al. (1997). Functional identification of the mouse circadian clock gene by transgenic BAC rescue. Cell. 89:655–67
   PubMed Web of Science ®Google Scholar
• Balsalobre A, Brown SA, Marcacci L, et al. (2000a). Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science. 289:2344–7
   PubMed Web of Science ®Google Scholar
• Balsalobre A, Brown SA, Marcacci L, et al. (2000b). Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science. 289:2344–7
   PubMed Web of Science ®Google Scholar
• Balsalobre A, Damiola F, Schibler U. (1998). A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell. 93:929–37
   PubMed Web of Science ®Google Scholar
• Buhr ED, Yoo SH, Takahashi JS. (2010). Temperature as a universal resetting cue for mammalian circadian oscillators. Science. 330:379–85
   PubMed Web of Science ®Google Scholar
• Cao Q, Gery S, Dashti A, et al. (2009). A role for the clock gene Per1 in prostate cancer. Cancer Res. 69:7619–25
   PubMed Web of Science ®Google Scholar
• Chevalier V, Mormont M-C, Curé H, Chollet P. (2003). Assessment of circadian rhythms by actimetry in healthy subjects and patients with advanced colorectal cancer. Oncol Rep. 10:733–7
   PubMed Web of Science ®Google Scholar
• Comas M, Beersma DG, Hut RA, Daan S. (2008). Circadian phase resetting in response to light-dark and dark-light transitions. J Biol Rhythms. 23:425–34
   PubMed Web of Science ®Google Scholar
• Damiola F. (2000). Restricted feeding uncouples circadian oscillators in peripheral tissues from the central pacemaker in the suprachiasmatic nucleus. Genes Develop. 14:2950–61
   PubMed Web of Science ®Google Scholar
• Dibner C, Schibler U, Albrecht U. (2010). The mammalian circadian timing system: Organization and coordination of central and peripheral clocks. Ann Rev Physiol. 72:517–49
   PubMed Web of Science ®Google Scholar
• Donehower LA, Harvey M, Slagle BL, et al. (1992). Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:215–21
   PubMed Web of Science ®Google Scholar
• Gamaleia NF, Lisnyak IA, Shishko ED, et al. (2012). Chronobiological approaches to antiangiogenic photodynamic therapy of tumors: The first experimental evaluation. Exp Oncol. 34:364–6
   PubMedGoogle Scholar
• Gery S, Komatsu N, Baldjyan L, et al. (2006). The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell. 22:375–82
   PubMed Web of Science ®Google Scholar
• Geusz ME, Blakely KT, Hiler DJ, Jamasbi RJ. (2010). Elevated mPer1 gene expression in tumor stroma imaged through bioluminescence. Int J Cancer. 126:620–30
   Google Scholar
• Gorbacheva VY, Kondratov RV, Zhang R, et al. (2005). Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci USA. 102:3407–12
   PubMed Web of Science ®Google Scholar
• Grutsch J, Ferrans C, Wood P, et al. (2011). The association of quality of life with potentially remediable disruptions of circadian sleep/activity rhythms in patients with advanced lung cancer. BMC Cancer. 11:193
   PubMed Web of Science ®Google Scholar
• Hara R, Wan K, Wakamatsu H, et al. (2001). Restricted feeding entrains liver clock without participation of the suprachiasmatic nucleus. Genes Cells. 6:269–78
   PubMed Web of Science ®Google Scholar
• Hirota T, Okano T, Kokame K, et al. (2002). Glucose down-regulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J Biol Chem. 277:44244–51
   PubMed Web of Science ®Google Scholar
• Hsu C-M, Lin S-F, Lu C-T, et al. (2012). Altered expression of circadian clock genes in head and neck squamous cell carcinoma. Tumor Biol. 33:149–55
   PubMed Web of Science ®Google Scholar
• Hu Y, Spengler ML, Kuropatwinski KK, et al. (2011). Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1. Oncotarget. 2:1279–90
   PubMedGoogle Scholar
• Innominato PF, Focan C, Gorlia T, et al. (2009a). Circadian rhythm in rest and activity: A biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 69:4700–7
   PubMed Web of Science ®Google Scholar
• Innominato PF, Mormont M-C, Rich TA, et al. (2009b). Circadian disruption, fatigue, and anorexia clustering in advanced cancer patients: Implications for innovative therapeutic approaches. Integra Cancer Ther. 8:361–70
   PubMed Web of Science ®Google Scholar
• Krugluger W, Brandstaetter A, Kállay E, et al. (2007). Regulation of genes of the circadian clock in human colon cancer: Reduced period-1 and dihydropyrimidine dehydrogenase transcription correlates in high-grade tumors. Cancer Res. 67:7917–22
   PubMed Web of Science ®Google Scholar
• Lévi F, Filipski E, Iurisci I, et al. (2007). Cross-talks between circadian timing system and cell division cycle determine cancer biology and therapeutics. Cold Spring Harbor Symp Quan Biol. 72:465–75
   PubMedGoogle Scholar
• Lévi F, Okyar A, Dulong S, et al. (2010). Circadian timing in cancer treatments. Ann Rev Pharmacol Toxicol. 50:377–421
   PubMed Web of Science ®Google Scholar
• Levi F, Schibler U. (2007). Circadian rhythms: Mechanisms and therapeutic implications. Ann Rev Pharmacol Toxicol. 47:593–628
   PubMed Web of Science ®Google Scholar
• Lin Y-M, Chang JH, Yeh K-T, et al. (2008). Disturbance of circadian gene expression in hepatocellular carcinoma. Mol Carcinogen. 47:925–33
   PubMed Web of Science ®Google Scholar
• Lincoln GA, Clarke IJ, Hut RA, Hazlerigg DG. (2006). Characterizing a mammalian circannual pacemaker. Science. 314:1941–4
   PubMed Web of Science ®Google Scholar
• Liu AC, Tran HG, Zhang EE, et al. (2008). Redundant function of REV-ERBα and β and non-essential role for Bmal1 cycling in transcriptional regulation of intracellular circadian rhythms. PLoS Genet. 4:e1000023
   PubMed Web of Science ®Google Scholar
• Mohawk JA, Green CB, Takahashi JS. (2012). Central and peripheral circadian clocks in mammals. Ann Rev Neurosci. 35:445–62
   PubMed Web of Science ®Google Scholar
• Mormont MC, Lévi F. (1997). Circadian-system alterations during cancer processes: A review. Int J Cancer. 70:241–7
   PubMed Web of Science ®Google Scholar
• Mormont MC, Waterhouse J, Bleuzen P, et al. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res. 6:3038–45
   PubMed Web of Science ®Google Scholar
• Morse HC, Anver MR, Fredrickson TN, et al. (2002). Bethesda proposals for classification of lymphoid neoplasms in mice. Blood. 100:246–58
   PubMed Web of Science ®Google Scholar
• Mostafaie N, Kállay E, Sauerzapf E, et al. (2009). Correlated downregulation of estrogen receptor beta and the circadian clock gene Per1 in human colorectal cancer. Mol Carcinogen. 48:642–7
   PubMed Web of Science ®Google Scholar
• Ortiz-Tudela E, Mteyrek A, Ballesta A, et al. (2013). Cancer chronotherapeutics: Experimental, theoretical, and clinical aspects. In Kramer A, Merrow M, eds. Circadian clocks. Berlin–Heidelberg: Springer, pp. 261–88
   Google Scholar
• Panda S, Antoch MP, Miller BH, et al. (2002). Coordinated transcription of key pathways in the mouse by the circadian clock. Cell. 109:307–20
   PubMed Web of Science ®Google Scholar
• Partch CL, Green CB, Takahashi JS. (2013). Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 24:90–9
   PubMed Web of Science ®Google Scholar
• Pogue-Geile KL, Lyons-Weiler J, Whitcomb DC. (2006). Molecular overlap of fly circadian rhythms and human pancreatic cancer. Cancer Lett. 243:55–7
   Google Scholar
• Portaluppi F, Smolensky MH, Touitou Y. (2010). Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 27:1911–29
   PubMed Web of Science ®Google Scholar
• Preitner N, Damiola F, Luis Lopez M, et al. (2002). The orphan nuclear receptor REV-ERB± controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell. 110:251–60
   PubMed Web of Science ®Google Scholar
• Relles D, Sendecki J, Chipitsyna G, et al. (2013). Circadian gene expression and clinicopathologic correlates in pancreatic cancer. J Gastrointest Surg. 17:443–50
   PubMed Web of Science ®Google Scholar
• Rossetti S, Esposito J, Corlazzoli F, et al. (2012). Entrainment of breast (cancer) epithelial cells detects distinct circadian oscillation patterns for clock and hormone receptor genes. Cell Cycle. 11:350–60
   PubMed Web of Science ®Google Scholar
• Sato F, Nagata C, Liu Y, et al. (2009). PERIOD1 is an anti-apoptotic factor in human pancreatic and hepatic cancer cells. J Biochem. 146:833–8
   PubMed Web of Science ®Google Scholar
• Sephton S, Spiegel D. (2003). Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease? Brain Behav Immunity. 17:321–8
   PubMed Web of Science ®Google Scholar
• Sladek M, Sumova A. (2013). Entrainment of spontaneously hypertensive rat fibroblasts by temperature cycles. PLoS One. 8:e77010
   PubMed Web of Science ®Google Scholar
• Stokkan K-A, Yamazaki S, Tei H, et al. (2001). Entrainment of the circadian clock in the liver by feeding. Science. 291:490–3
   PubMed Web of Science ®Google Scholar
• Tahara Y, Otsuka M, Fuse Y, et al. (2011). Refeeding after fasting elicits insulin-dependent regulation of Per2 and Rev-erbalpha with shifts in the liver clock. J Biol Rhythms. 26:230–40
   PubMed Web of Science ®Google Scholar
• Takahashi JS, Hong H-K, Ko CH, McDearmon EL. (2008). The genetics of mammalian circadian order and disorder: Implications for physiology and disease. Nat Rev Genet. 9:764–75
   PubMed Web of Science ®Google Scholar
• Tokunaga H, Takebayashi Y, Utsunomiya H, et al. (2008). Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer. Acta Obstetr Gynecol Scandinavica. 87:1060–70
   PubMed Web of Science ®Google Scholar
• Vitaterna MH, King DP, Chang AM, et al. (1994). Mutagenesis and mapping of a mouse gene, clock, essential for circadian behavior. Science (New York, NY). 264:719–25
   Google Scholar
• Winter SL, Bosnoyan-Collins L, Pinnaduwagez D, Andrulis IL. (2007). Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia. 9:797–800
   PubMed Web of Science ®Google Scholar
• Xia H-C, Niu Z-F, Ma H, et al. (2010). Deregulated expression of the Per1 and Per2 in human gliomas. Can J Neurolog Sci. 37:365–70
   PubMed Web of Science ®Google Scholar
• Yamazaki S, Takahashi JS. (2005). Real-time luminescence reporting of circadian gene expression in mammals. Method Enzymol. 393:288–301
   Google Scholar
• Yeh K-T, Yang M-Y, Liu T-C, et al. (2005). Abnormal expression of period 1 (PER1) in endometrial carcinoma. J Pathol. 206:111–20
   PubMed Web of Science ®Google Scholar
• Yoo S-H, Yamazaki S, Lowrey PL, et al. (2004). PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc Natl Acad Sci USA. 101:5339–46
   PubMed Web of Science ®Google Scholar
• Yu EA, Weaver DR. (2011). Disrupting the circadian clock: Gene-specific effects on aging, cancer, and other phenotypes. Aging. 3:479–93
   PubMedGoogle Scholar
• Yu H, Meng X, Wu J, et al. (2013). Cryptochrome 1 overexpression correlates with tumor progression and poor prognosis in patients with colorectal cancer. PLoS One 8:1–10
   Web of Science ®Google Scholar